<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01204970</url>
  </required_header>
  <id_info>
    <org_study_id>B32220109292</org_study_id>
    <nct_id>NCT01204970</nct_id>
  </id_info>
  <brief_title>Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant Recipients</brief_title>
  <official_title>Confocal Laser Micro-endoscopy: New Insights in COPD and Lung Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KU Leuven</source>
  <brief_summary>
    <textblock>
      Aspects of confocal laser micro-endoscopy (CLME) and morphometry in chronic obstructive&#xD;
      pulmonary disease (COPD) and lung transplant recipients is described and will be correlated&#xD;
      with clinical findings in order to described small airway remodelling in these patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In early phases of COPD, changes in small airway characteristics may develop. Elastin decay&#xD;
      and matrix remodelling could be responsible for these changes. Using CLME changes of in the&#xD;
      bronchiolar wall and alveolar ducts can be visualized, described and measured.&#xD;
&#xD;
      In lung transplant recipients, CMLE will be performed to distinguish characteristics of&#xD;
      distal airways in stabile patient in contrast to patients with bronchiolitis obliterans&#xD;
      syndrome.&#xD;
&#xD;
      In both groups data will be correlated with CT findings, pulmonary function tests and&#xD;
      anatomopathological results.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>morphometry</measure>
    <time_frame>90 - 180 - 360 - 540 - 720 days</time_frame>
    <description>morpohometrical analysis at different time point after lung transplantation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>90 - 180 - 360- 540- 720 days</time_frame>
    <description>bleeding, pneumothorax, pleuritic chest pain during procedure</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">176</enrollment>
  <condition>Lung Transplantation</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>COPD</arm_group_label>
    <description>COPD Gold class 1-4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transplant</arm_group_label>
    <description>Lung transplant recipients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients with normal spirometric data</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for a bronchoscopic procedure will be asked to undergo CLME. 3 pools will&#xD;
        be made: COPD patients according to their pulmonary function test, lung transplant&#xD;
        recipients and patients with normal spirometric results. In all groups the difference&#xD;
        between active smokers and no-smokers will be made.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  referral for bronchoscopic investigation/sampling&#xD;
&#xD;
          -  informed consent signed&#xD;
&#xD;
          -  recent spirometric data&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  sedated and/or ventilated patients&#xD;
&#xD;
          -  patients on ICU&#xD;
&#xD;
          -  patients under oral anticoagulation&#xD;
&#xD;
          -  co-existing lung disease&#xD;
&#xD;
          -  acute infectious pulmonary disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonas Yserbyt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chistophe Dooms, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Decramer, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Geert Verleden, Md, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wim Janssens, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>September 17, 2010</study_first_submitted>
  <study_first_submitted_qc>September 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2010</study_first_posted>
  <last_update_submitted>December 29, 2016</last_update_submitted>
  <last_update_submitted_qc>December 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>KU Leuven</investigator_affiliation>
    <investigator_full_name>Marc Decramer</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Confocal Laser Scanning Microendoscopy</keyword>
  <keyword>Small airways</keyword>
  <keyword>COPD</keyword>
  <keyword>Lung transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

